{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-015584","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.211125+00:00","generated_at":"2026-05-19T03:27:30.337300+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Biofrontera shareholders approve doubling authorized shares to 70M at annual meeting","bullets":["Heikki Lanckriet elected Class I director with 4,565,450 votes for, 329,105 withheld.","Amendment to increase authorized common shares from 35M to 70M approved (5,499,898 for, 837,939 against).","Adjournment proposal approved (5,716,131 for) to allow further solicitation if needed.","Ratification of CBIZ CPAs P.C. as auditor for FY2025 approved (6,144,222 for)."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-015584","json":"https://secwatch.observer/filing/0001641172-25-015584.json","markdown":"https://secwatch.observer/filing/0001641172-25-015584.md","text":"https://secwatch.observer/filing/0001641172-25-015584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000164117225015584/0001641172-25-015584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000164117225015584/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T03:27:30.337300+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}